Hepatitis C virus infection in Western Europe

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 80-83

  Trepo C ^a   Pradat, P ^a  

^a HÔTEL DIEU   (France)

Author keywords

Epidemiology; Europe; Hepatitis C; Incidence; Prevalence

Indexed keywords

CONFERENCE PAPER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; PREVALENCE; PRIORITY JOURNAL; SCREENING; VIRUS TRANSMISSION; WESTERN EUROPE;

EID: 0033451928     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80379-1     Document Type: Conference Paper

References (32)

1. Kew MC. Hepatitis C virus and hepatocellular carcinoma in developing and developed countries. Viral Hepatitis 1998: 4: 259269.
2. World Health Organization, Weekly Epidemioloaical Record 1997: 72: 65-72.
3. HENCORE: Hepatitis C European Network for Co-Operative Research. Guidelines for control and management of hepatitis C. Report to the European Commission DG V: March 1998.
4. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997: 26: 1006-1011.
5. Osella AR, Misciagna G, Leone A, Di Leo A, Fiore G. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol 1997: 27: 30-53.
6. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997: 26: 62S-65S.
7. Coppola RC, Rizzetto M, Bradley DW. Hepatitis C. In: Crivelli O, editor. Viral Hepatitis Handbook, 1996. p. 65.
8. Roffi L, Ricci A, Ogliari C, Scalori A, Minola E, Colloredo G, et al. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol 1998: 29: 701-706.
9. Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors of HCV infection among Elisa-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology 1993: 17: 183-187. .
10. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996: 334: 1691-1696.
11. Zeuzem S, Teuber G, Lee JH, Rüster B, Roth WK. Risk factors for the transmission of hepatitis C. J Hepatol 1996: 24: 3-10.
12. Touzet S, Kraemer L, Colin C, Pradat P, Bailly F, Coppola RC, et al. Prevalence and incidence rates of hepatitis C antibodies in seven countries of the European Union. Critical analysis of the literature (Submitted).
13. Sulkowski MS, Thomas DL. Viral hepatitis among injection drug users. Viral Hepatitis 1998: 4: 229-244.
14. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus among young adult injection drug users. J Acq Immune Defic Syndr Hum Retrovirol 1998: 18 SuppI 1: S11-S19.
15. Galeazzi B, Tufano A, Barbierato E, Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 1995: 15: 209-212.
16. Broers B, Junet C, Bourquin M, Déglon J-J, Perrin L, Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 1998: 12: 2059-2066.
17. Mclntyre PG, McCruden EA, Dow BC, Cameron SO, McMillan MA, Allison ME, et al. Hepatitis C virus infection in renal dialysis patients in Glaseow. Nephrol Dial Transplant 1994: 9: 291295.
18. Nordenfeit E, Löfgren B, Widell A, Hansson BG, Zhang YY, Hagstam KE, et al. Hepatitis C virus infection in hemodialysis patients in southern Sweden: epidemiological, clinical, and diagnostics aspects. J Med Virol 1993: 40: 266-270.
19. Garcia Valdecasas J, Bernai C, Cerezo S, Garcia F, Montiel N, Leyva A et al. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels. ASAIO J 1994: 40: M450-M453.
20. De Lamballerie X, Olmer M, Bouchouared D, Zandotti C, De Micco P. Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol 1996: 49: 296-302.
21. Vitale C, Tricerri A, Marangella M, Vacha GM, Giorcelli G, Marini C et al. Epidemiology of hepatitis C virus infection in dialysis units: first- versus second-generation assays. Nephron 1993: 64: 315-316.
22. Simon N, Couroucé AM, Lemarrec N, Trépo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994: 46: 504-511.
23. Forns X, Fernandez-Llama P, Pons M, Costa J, Ampurdanes S, Lopez-Labrador FX et al. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 1997: 12: 736-740.
24. Comandini UV, Tossini G, Longo MA, Ferri F, Cuzzi G, Noto P et al. Sporadic hepatitis C virus infection: a case-control study of transmission routes in a selected hospital sample of the general population in Italy. Scand J Infect Dis 1998: 30: 11-15.
25. Van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ et al. Infectivity of blood séropositive for hepatitis C virus antibodies. Lancet 1990: 335: 558560.
26. Desenclos JC, Dubois F, Couturier E, Roudot TF, Pillonet J, Brunei JB et al. Prévalence de l'infection par le VHC en France en 1994. Communication personnelle. Réseau National de Santé Publique. Action Concertée Hépatite C, 1995.
27. Hédouin V, Gösset D. Infection par le virus de l'hépatite C en milieu carcéral. Etude prospective réalisée àLoos-Iez-Lille. Gastroenterol Clin Biol 1998: 22: 55-58.
28. Jury de la Conférence de Consensus. Conclusions et recommandations du Jury. Hépatite C: dépistage et traitement. Gastroenterol Clin Biol 1997: 20 (Suppl. Ib): S202-S211.
29. Roudot-Thoraval F. L'hépatite C en milieu carcéral: faut-il dé pister? Gastroenterol Clin Biol 1998: 22: 4112.
30. Shapiro S, Gershtein V, Elias N, Zuckerman E, Salman N, Lahat N. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferonalpha (IFN-alpha) treatment. Clin Exp Immunol 1998: 114: 5560.
31. Craxi A, Di Marco V, Camma C, Almasio P, Magrin S. Duration of HCV infection as a predictor of nonresponse to interferon. DigDisScil996:41:86S-92S.
32. Nalpas B, Delaroques-Astagneau E, Bihan CL, Drucker J, Desenclos JC. Medical practices regarding hepatitis C virus infection in Europe. J Viral Hepat 1998: 5: 131-141.